10-Q
false0001556898--12-31Q300015568980001556898http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 20230001556898ck0001556898:AutomotiveMember2023-01-012023-09-300001556898ck0001556898:SecuritySurveillanceMember2024-01-012024-09-300001556898ck0001556898:TwoThousandSeventeenStockOptionPlanMember2024-01-012024-01-010001556898country:JP2024-07-012024-09-300001556898us-gaap:RetainedEarningsMember2024-01-012024-03-310001556898country:JP2023-01-012023-09-300001556898ck0001556898:TwoThousandTwelveStockOptionPlanMember2017-09-300001556898ck0001556898:LongTermInvestmentsMember2023-12-310001556898us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001556898us-gaap:USTreasurySecuritiesMember2024-09-300001556898us-gaap:RestrictedStockUnitsRSUMemberck0001556898:TwoThousandSeventeenStockOptionPlanMember2024-01-012024-09-300001556898us-gaap:CostOfSalesMember2023-07-012023-09-300001556898ck0001556898:O2023ASecondInstallmentDividendsMember2024-01-012024-09-3000015568982024-09-300001556898ck0001556898:ExercisePriceTwoPointFiveOneMember2024-09-300001556898us-gaap:AgencySecuritiesMember2024-09-300001556898srt:MaximumMemberck0001556898:TwoThousandSeventeenStockOptionPlanMember2017-09-012017-09-300001556898country:KR2024-01-012024-09-3000015568982024-07-012024-09-300001556898us-gaap:RestrictedStockUnitsRSUMemberck0001556898:TwoThousandSeventeenStockOptionPlanMember2023-12-310001556898us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898ck0001556898:O2023ADividendsMember2022-12-160001556898us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898exch:XJPXck0001556898:JapaneseDepositarySharesMember2024-01-012024-09-300001556898ck0001556898:O2023ADividendsMember2022-12-162022-12-160001556898us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:CommonStockMember2022-12-310001556898country:CN2024-09-300001556898us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100015568982023-04-012023-06-300001556898ck0001556898:SecuritySurveillanceMember2023-01-012023-09-300001556898country:TW2023-12-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001556898us-gaap:RetainedEarningsMember2024-06-300001556898us-gaap:CommonStockMember2023-04-012023-06-3000015568982024-06-300001556898us-gaap:RetainedEarningsMember2024-03-310001556898ck0001556898:ExercisePriceZeroPointThreeSevenMember2024-09-300001556898ck0001556898:TwoThousandTwelveStockOptionPlanMember2017-09-012017-09-300001556898ck0001556898:TwoThousandTwelveStockOptionPlanMember2024-01-012024-09-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898ck0001556898:OtherCountriesMember2024-01-012024-09-3000015568982023-06-300001556898us-gaap:CorporateBondSecuritiesMember2023-12-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001556898ck0001556898:CommonStockWithParValueMember2024-01-012024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001556898ck0001556898:O2024ADividendsMember2023-12-1500015568982023-07-012023-09-300001556898us-gaap:RetainedEarningsMember2023-04-012023-06-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001556898us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:USTreasurySecuritiesMember2023-12-310001556898us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898country:JP2024-01-012024-09-300001556898us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberck0001556898:EndCustomerAMember2023-01-012023-09-300001556898country:KR2023-01-012023-09-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:AgencySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898us-gaap:CommonStockMember2023-06-300001556898country:CN2024-07-012024-09-300001556898us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001556898us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AgencySecuritiesMember2024-09-300001556898ck0001556898:OtherCountriesMember2023-07-012023-09-300001556898us-gaap:ShortTermInvestmentsMember2024-09-300001556898us-gaap:CashAndCashEquivalentsMember2023-12-310001556898us-gaap:FairValueInputsLevel1Memberus-gaap:AgencySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898country:CN2023-07-012023-09-300001556898us-gaap:RetainedEarningsMember2023-01-012023-03-310001556898ck0001556898:O2024ADividendsMember2023-12-152023-12-150001556898ck0001556898:O2024ASecondInstallmentDividendsMember2024-01-012024-09-300001556898us-gaap:AdditionalPaidInCapitalMember2023-03-310001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-09-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-3000015568982023-01-012023-12-310001556898us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001556898us-gaap:CommonStockMember2024-03-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001556898ck0001556898:O2024AFirstInstallmentDividendsMember2023-12-150001556898us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001556898us-gaap:CommonStockMember2023-07-012023-09-300001556898us-gaap:AdditionalPaidInCapitalMember2023-12-310001556898us-gaap:CommonStockMember2024-01-012024-03-310001556898country:KR2023-12-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001556898us-gaap:CommonStockMember2024-09-300001556898ck0001556898:SecuritySurveillanceMember2024-07-012024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000015568982023-01-012023-03-310001556898us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberck0001556898:EndCustomerAMember2024-07-012024-09-300001556898country:US2023-12-310001556898country:KR2024-07-012024-09-300001556898us-gaap:AdditionalPaidInCapitalMember2024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001556898us-gaap:StateAndLocalJurisdictionMember2024-01-012024-09-300001556898us-gaap:RetainedEarningsMember2023-07-012023-09-300001556898us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-3000015568982023-07-310001556898ck0001556898:O2024ADividendsMember2023-01-012023-12-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001556898us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898ck0001556898:ExercisePriceZeroPointNineSevenMember2024-01-012024-09-3000015568982023-01-012023-09-300001556898us-gaap:CertificatesOfDepositMember2023-12-310001556898country:JP2024-09-3000015568982024-01-012024-03-310001556898ck0001556898:ExercisePriceTwoPointFiveOneMember2024-01-012024-09-3000015568982023-03-310001556898country:TW2023-01-012023-09-300001556898us-gaap:RetainedEarningsMember2024-07-012024-09-300001556898us-gaap:CostOfSalesMember2023-01-012023-09-300001556898country:JP2023-12-310001556898ck0001556898:O2023AFirstInstallmentDividendsMember2022-12-160001556898us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001556898us-gaap:FurnitureAndFixturesMember2023-12-310001556898us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:AgencySecuritiesMember2023-12-310001556898us-gaap:RetainedEarningsMember2022-12-310001556898us-gaap:ShortTermInvestmentsMember2023-12-310001556898ck0001556898:SecuritySurveillanceMember2023-07-012023-09-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AgencySecuritiesMember2023-12-310001556898us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001556898country:TW2024-07-012024-09-300001556898us-gaap:RestrictedStockUnitsRSUMemberck0001556898:TwoThousandSeventeenStockOptionPlanMember2024-09-300001556898us-gaap:CostOfSalesMember2024-01-012024-09-300001556898us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AgencySecuritiesMember2023-12-310001556898country:TW2024-01-012024-09-300001556898ck0001556898:ExercisePriceZeroPointNineSevenMember2024-09-300001556898country:TW2023-07-012023-09-300001556898ck0001556898:O2023ASecondInstallmentDividendsMember2022-12-162022-12-160001556898us-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerAMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-09-300001556898us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberck0001556898:EndCustomerAMember2023-07-012023-09-300001556898ck0001556898:ExercisePriceTwoPointNineThreeMember2024-01-012024-09-300001556898us-gaap:CashAndCashEquivalentsMember2024-09-300001556898us-gaap:CostOfSalesMember2024-07-012024-09-300001556898us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898country:KR2024-09-300001556898us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001556898us-gaap:AdditionalPaidInCapitalMember2023-06-300001556898country:TW2024-09-300001556898us-gaap:RetainedEarningsMember2024-09-300001556898ck0001556898:O2024ASecondInstallmentDividendsMember2024-05-3100015568982024-01-012024-09-3000015568982023-12-310001556898stpr:CA2024-01-012024-09-3000015568982024-04-012024-06-300001556898us-gaap:CommonStockMember2024-07-012024-09-300001556898us-gaap:LeaseholdImprovementsMember2024-09-300001556898ck0001556898:TwentySeventeenStockIncentivePlanMember2024-09-300001556898us-gaap:RetainedEarningsMember2023-06-300001556898srt:MinimumMemberck0001556898:TwoThousandTwelveStockOptionPlanMember2012-04-012012-04-300001556898us-gaap:AdditionalPaidInCapitalMember2024-03-310001556898ck0001556898:OtherCountriesMember2023-01-012023-09-300001556898us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001556898us-gaap:RetainedEarningsMember2023-03-310001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001556898ck0001556898:ExercisePriceZeroPointThreeSevenMember2024-01-012024-09-300001556898country:CN2024-01-012024-09-300001556898ck0001556898:ExercisePriceTwoPointEightNineMember2024-01-012024-09-300001556898country:KR2023-07-012023-09-300001556898us-gaap:CommonStockMember2023-12-310001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001556898ck0001556898:ExercisePriceThreePointOneEightMember2024-09-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001556898us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001556898ck0001556898:OutstandingStockAwardsMember2024-09-300001556898us-gaap:RetainedEarningsMember2024-04-012024-06-3000015568982023-09-300001556898us-gaap:RetainedEarningsMember2023-09-300001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerAMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001556898ck0001556898:ExercisePriceTwoPointEightNineMember2024-09-300001556898us-gaap:CommonStockMember2023-01-012023-03-310001556898us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001556898ck0001556898:AutomotiveMember2023-07-012023-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001556898srt:MinimumMemberck0001556898:TwoThousandTwelveStockOptionPlanMember2012-04-300001556898us-gaap:CommonStockMember2023-03-310001556898ck0001556898:ExercisePriceThreePointOneEightMember2024-01-012024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001556898country:US2024-09-300001556898us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberck0001556898:EndCustomerAMember2024-01-012024-09-300001556898us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerAMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001556898us-gaap:FurnitureAndFixturesMember2024-09-300001556898us-gaap:RetainedEarningsMember2023-12-310001556898ck0001556898:O2023AFirstInstallmentDividendsMember2024-01-012024-09-300001556898us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001556898ck0001556898:MachineryComputerEquipmentAndSoftwareMember2023-12-310001556898us-gaap:CommonStockMember2024-06-300001556898us-gaap:AdditionalPaidInCapitalMember2022-12-310001556898ck0001556898:O2024AFirstInstallmentDividendsMember2024-01-012024-09-300001556898us-gaap:CorporateBondSecuritiesMember2024-09-300001556898ck0001556898:TwoThousandTwelveStockOptionPlanMembersrt:MaximumMember2012-04-012012-04-300001556898ck0001556898:OtherCountriesMember2024-07-012024-09-300001556898ck0001556898:O2023ASecondInstallmentDividendsMember2023-06-020001556898ck0001556898:AutomotiveMember2024-07-012024-09-3000015568982022-12-310001556898ck0001556898:TwoThousandSeventeenStockOptionPlanMember2024-01-012024-09-300001556898us-gaap:CommonStockMember2023-09-300001556898ck0001556898:O2024ADividendsMember2024-01-012024-09-300001556898us-gaap:LeaseholdImprovementsMember2023-12-3100015568982024-11-030001556898us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001556898us-gaap:AdditionalPaidInCapitalMember2024-06-300001556898us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001556898ck0001556898:AutomotiveMember2024-01-012024-09-300001556898srt:MaximumMemberck0001556898:TwoThousandSeventeenStockOptionPlanMember2024-01-012024-09-300001556898ck0001556898:MachineryComputerEquipmentAndSoftwareMember2024-09-3000015568982024-03-310001556898ck0001556898:ExercisePriceTwoPointNineThreeMember2024-09-300001556898us-gaap:CommonStockMember2024-04-012024-06-300001556898us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898country:CN2023-12-310001556898us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001556898us-gaap:CertificatesOfDepositMember2024-09-300001556898us-gaap:AdditionalPaidInCapitalMember2023-09-300001556898country:CN2023-01-012023-09-300001556898us-gaap:SalesRevenueNetMemberck0001556898:CustomerAMemberus-gaap:CustomerConcentrationRiskMember2024-07-012024-09-300001556898us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001556898stpr:DE2024-01-012024-09-300001556898country:JP2023-07-012023-09-300001556898us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-31ck0001556898:Installmentck0001556898:Segmentck0001556898:Litigationxbrli:pureck0001556898:Leasexbrli:sharesck0001556898:Investmentiso4217:USDxbrli:sharesck0001556898:Officeiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

Commission File Number: 000-55843

 

Techpoint, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

80-0806545

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

2550 N. First Street, #550

San Jose, CA USA 95131

(Address of principal executive offices) (Zip Code)

 

(408) 324-0588

(Registrant’s telephone number,

including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Japanese Depositary Shares, each representing one

share of Common Stock, $0.0001 par value per share

 

M-6697

 

Tokyo Stock Exchange (Growth Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 3, 2024, the registrant had 18,595,624 shares of common stock, $0.0001 par value per share, outstanding.

 


Table of Contents.

 

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

1

Condensed Consolidated Balance Sheets

1

Condensed Consolidated Statements of Income and Comprehensive Income

2

 

Condensed Consolidated Statements of Stockholders’ Equity

3

Condensed Consolidated Statements of Cash Flows

5

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

30

Item 4.

Controls and Procedures

31

PART II.

OTHER INFORMATION

32

Item 1.

Legal Proceedings

32

Item 1A.

Risk Factors

32

Item 5.

Other Information

32

Item 6.

Exhibits

33

 

SIGNATURES

34

 


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Techpoint, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts, unaudited)

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

46,191

 

 

$

13,671

 

Short-term investments

 

 

22,283

 

 

 

51,788

 

Accounts receivable

 

 

176

 

 

 

40

 

Inventory

 

 

13,654

 

 

 

9,518

 

Prepaid expenses and other current assets

 

 

877

 

 

 

939

 

Total current assets

 

 

83,181

 

 

 

75,956

 

Property and equipment, net

 

 

400

 

 

 

522

 

Deferred tax assets

 

 

4,522

 

 

 

3,620

 

Right-of-use assets

 

 

1,152

 

 

 

1,045

 

Goodwill

 

 

891

 

 

 

891

 

Intangible assets, net

 

 

954

 

 

 

1,036

 

Long-term investments

 

 

 

 

 

500

 

Other assets

 

 

179

 

 

 

237

 

Total assets

 

$

91,279

 

 

$

83,807

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

1,350

 

 

$

1,707

 

Accrued liabilities

 

 

4,030

 

 

 

2,322

 

Customer deposits

 

 

1,995

 

 

 

1,448

 

Lease liabilities

 

 

675

 

 

 

497

 

Dividend payable

 

 

 

 

 

4,599

 

Total current liabilities

 

 

8,050

 

 

 

10,573

 

Other liabilities

 

 

656

 

 

 

939

 

Total liabilities

 

 

8,706

 

 

 

11,512

 

Commitments and contingencies (Note 5)

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

Preferred stock, par value $0.0001 per share - 5,000,000 shares authorized
   as of September 30, 2024 and December 31, 2023;
nil shares issued and
   outstanding as of September 30, 2024 and December 31, 2023

 

 

 

 

 

 

Common stock, par value $0.0001 per share - 75,000,000 shares
   authorized as of September 30, 2024 and December 31, 2023;
18,585,141 and
   
18,395,682 shares issued and outstanding as of September 30, 2024 and
   December 31, 2023, respectively

 

 

2

 

 

 

2

 

Additional paid-in capital

 

 

28,595

 

 

 

27,477

 

Accumulated other comprehensive income

 

 

41

 

 

 

18

 

Retained earnings

 

 

53,935

 

 

 

44,798

 

Total stockholders’ equity

 

 

82,573

 

 

 

72,295

 

Total liabilities and stockholders’ equity

 

$

91,279

 

 

$

83,807

 

 

See accompanying notes to condensed consolidated financial statements.

1


 

Techpoint, Inc.

Condensed Consolidated Statements of Income and Comprehensive Income

(in thousands, except share and per share amounts, unaudited)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

$

18,486

 

 

$

17,511

 

 

$

51,576

 

 

$

46,951

 

Cost of revenue

 

 

8,690

 

 

 

8,143

 

 

 

24,275

 

 

 

21,711

 

Gross profit

 

 

9,796

 

 

 

9,368

 

 

 

27,301

 

 

 

25,240

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

2,583

 

 

 

1,803

 

 

 

6,502

 

 

 

5,346

 

Selling, general and administrative

 

 

2,404

 

 

 

2,255

 

 

 

7,528

 

 

 

7,148

 

Total operating expenses

 

 

4,987

 

 

 

4,058

 

 

 

14,030

 

 

 

12,494

 

Income from operations

 

 

4,809

 

 

 

5,310

 

 

 

13,271

 

 

 

12,746

 

Other income, net

 

 

911

 

 

 

550

 

 

 

2,343

 

 

 

1,504

 

Income before income taxes

 

 

5,720

 

 

 

5,860

 

 

 

15,614

 

 

 

14,250

 

Provision for income taxes

 

 

668

 

 

 

665

 

 

 

1,846

 

 

 

1,629

 

Net income

 

$

5,052

 

 

$

5,195

 

 

$

13,768

 

 

$

12,621

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.27

 

 

$

0.28

 

 

$

0.74

 

 

$

0.69

 

Diluted

 

$

0.27

 

 

$

0.28

 

 

$

0.73

 

 

$

0.68

 

Weighted average shares outstanding used in computing net income per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

18,571,666

 

 

 

18,353,552

 

 

 

18,492,688

 

 

 

18,293,535

 

Diluted

 

 

18,932,351

 

 

 

18,647,809

 

 

 

18,918,181

 

 

 

18,608,773

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

5,052

 

 

$

5,195

 

 

$

13,768

 

 

$

12,621

 

Other comprehensive income, net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on available-for-sale debt securities, net of tax expense of $1, $9, $7 and $9 for the three and nine months ended September 30, 2024 and 2023, respectively

 

 

2

 

 

 

17

 

 

 

23

 

 

 

18

 

Comprehensive income

 

$

5,054

 

 

$

5,212

 

 

$

13,791

 

 

$

12,639

 

See accompanying notes to condensed consolidated financial statements.

 

2


 

 

Techpoint, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts, unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional

 

 

Accumulated Other

 

 

 

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Paid-In Capital

 

 

Comprehensive income (loss)

 

 

Retained
Earnings

 

 

Stockholders'
Equity

 

Balances as of December 31, 2022

 

 

18,198,737

 

 

$

2

 

 

$

26,046

 

 

$

(147

)

 

$

36,175

 

 

$

62,076

 

Other comprehensive income – gain on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

32

 

 

 

 

 

 

32

 

Issuance of common stock upon exercise of stock options

 

 

24,600

 

 

 

 

 

 

29

 

 

 

 

 

 

 

 

 

29

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

32,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(4,636

)

 

 

 

 

 

(35

)

 

 

 

 

 

 

 

 

(35

)

Stock-based compensation

 

 

 

 

 

 

 

 

362

 

 

 

 

 

 

 

 

 

362

 

Cash dividend adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4

)

 

 

(4

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,376

 

 

 

3,376

 

Balances as of March 31, 2023

 

 

18,251,126

 

 

$

2

 

 

$

26,402

 

 

$

(115

)

 

$

39,547

 

 

$

65,836

 

Other comprehensive loss – unrealized loss on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

(31

)

 

 

 

 

 

(31

)

Issuance of common stock upon exercise of stock options

 

 

3,250

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

10

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

82,325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(6,110

)

 

 

 

 

 

(41

)

 

 

 

 

 

 

 

 

(41

)

Stock-based compensation

 

 

 

 

 

 

 

 

368

 

 

 

 

 

 

 

 

 

368

 

Cash dividends declared ($0.25 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,583

)

 

 

(4,583

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,050

 

 

 

4,050

 

Balances as of June 30, 2023

 

 

18,330,591

 

 

$

2

 

 

$

26,739

 

 

$

(146

)

 

$

39,014

 

 

$

65,609

 

Other comprehensive income – unrealized gain on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

17

 

 

 

 

 

 

17

 

Issuance of common stock upon exercise of stock options

 

 

1,690

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

3

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

37,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(6,643

)

 

 

 

 

 

(46

)

 

 

 

 

 

 

 

 

(46

)

Stock-based compensation

 

 

 

 

 

 

 

 

406

 

 

 

 

 

 

 

 

 

406

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,195

 

 

 

5,195

 

Balances as of September 30, 2023

 

 

18,363,038

 

 

$

2

 

 

$

27,102

 

 

$

(129

)

 

$

44,209

 

 

$

71,184

 

See accompanying notes to condensed consolidated financial statements.

 

 

 

 

 

 

 

3


 

Techpoint, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts, unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional

 

 

Accumulated Other

 

 

 

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Paid-In Capital

 

 

Comprehensive
income

 

 

Retained
Earnings

 

 

Stockholders'
Equity

 

Balances as of December 31, 2023

 

 

18,395,682

 

 

$

2

 

 

$

27,477

 

 

$

18

 

 

$

44,798

 

 

$

72,295

 

Other comprehensive income – unrealized gain on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

4

 

Issuance of common stock upon exercise of stock options

 

 

13,000

 

 

 

 

 

 

57

 

 

 

 

 

 

 

 

 

57

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

27,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(3,807

)

 

 

 

 

 

(39

)

 

 

 

 

 

 

 

 

(39

)

Stock-based compensation

 

 

 

 

 

 

 

 

399

 

 

 

 

 

 

 

 

 

399

 

Cash dividend adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5

)

 

 

(5

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,380

 

 

 

4,380

 

Balances as of March 31, 2024

 

 

18,432,450

 

 

$

2

 

 

$

27,894

 

 

$

22

 

 

$

49,173

 

 

$

77,091

 

Other comprehensive income – unrealized gain on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

17

 

 

 

 

 

 

17

 

Issuance of common stock upon exercise of stock options

 

 

15,000

 

 

 

 

 

 

15

 

 

 

 

 

 

 

 

 

15

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

63,862

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(3,822

)

 

 

 

 

 

(32

)

 

 

 

 

 

 

 

 

(32

)

Stock-based compensation

 

 

 

 

 

 

 

 

395

 

 

 

 

 

 

 

 

 

395

 

Cash dividends declared ($0.25 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,626

)

 

 

(4,626

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,336

 

 

 

4,336

 

Balances as of June 30, 2024

 

 

18,507,490

 

 

$

2

 

 

$

28,272

 

 

$

39

 

 

$

48,883

 

 

$

77,196

 

Other comprehensive loss – unrealized loss on
   available-for-sale debt securities

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

2

 

Issuance of common stock upon exercise of stock options and vesting of early exercised options

 

 

11,400

 

 

 

 

 

 

33

 

 

 

 

 

 

 

 

 

33

 

Issuance of common stock upon vesting of
   restricted stock units

 

 

80,038

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares repurchased for tax withholdings on
   vesting of restricted stock units

 

 

(13,787

)

 

 

 

 

 

(110

)

 

 

 

 

 

 

 

 

(110

)

Stock-based compensation

 

 

 

 

 

 

 

 

400

 

 

 

 

 

 

 

 

 

400

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,052

 

 

 

5,052

 

Balances as of September 30, 2024

 

 

18,585,141

 

 

$

2

 

 

$

28,595

 

 

$

41

 

 

$

53,935

 

 

$

82,573

 

See accompanying notes to condensed consolidated financial statements.

 

4


 

Techpoint, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands, unaudited)

 

 

Nine Months Ended

 

 

 

September 30,

 

 

 

2024

 

 

2023

 

Cash Flows From Operating Activities

 

 

 

 

 

 

Net income

 

$

13,768

 

 

$

12,621

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

266

 

 

 

317

 

Stock-based compensation

 

 

1,194

 

 

 

1,136

 

Accretion of premium on available-for-sale investments

 

 

(976

)

 

 

(466

)

Gain on disposal of fixed asset

 

 

(132

)

 

 

 

Inventory valuation adjustment

 

 

50

 

 

 

296

 

Deferred income taxes

 

 

(878

)

 

 

(907

)

Noncash lease expense

 

 

544

 

 

 

402

 

Unrealized gain on available -for-sale investments

 

 

(233

)

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(136

)

 

 

16

 

Inventory

 

 

(4,187

)

 

 

1,944

 

Prepaid expenses and other current assets

 

 

112

 

 

 

(204

)

Other assets

 

 

60

 

 

 

33

 

Accounts payable

 

 

(167

)

 

 

(55

)

Accrued liabilities

 

 

1,408

 

 

 

1,270

 

Customer deposits

 

 

547

 

 

 

1,534

 

Lease liabilities

 

 

(163

)

 

 

(156

)

Other liabilities

 

 

(324

)

 

 

(252

)

Net cash provided by operating activities

 

 

10,753

 

 

 

17,529

 

Cash Flows From Investing Activities

 

 

 

 

 

 

Purchase of property and equipment

 

 

(120

)

 

 

(185

)

Acquisition of business and intangible assets

 

 

 

 

 

(1,700

)

Purchase of debt securities

 

 

(28,618

)

 

 

(27,732

)

Proceeds from maturities of debt securities

 

 

59,811

 

 

 

21,757

 

Net cash provided by (used in) investing activities

 

 

31,073

 

 

 

(7,860

)

Cash Flows From Financing Activities

 

 

 

 

 

 

Payment of dividends

 

 

(9,230

)

 

 

(9,137

)

Net proceeds from exercise of stock options

 

 

105

 

 

 

42

 

Payment for shares withheld for tax withholdings on vesting of restricted stock units

 

 

(181

)

 

 

(122

)

Net cash used in financing activities

 

 

(9,306

)

 

 

(9,217

)

Net increase in cash and cash equivalents

 

 

32,520

 

 

 

452

 

Cash and cash equivalents at beginning of period

 

 

13,671

 

 

 

19,392

 

Cash and cash equivalents at end of period

 

$

46,191

 

 

$

19,844

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

Cash paid for income taxes

 

$

3,251

 

 

$

2,408

 

Supplemental Disclosure of Noncash Investing and Financing Information

 

 

 

 

 

 

Right-of-use assets obtained in exchange for lease liabilities

 

$

651

 

 

$

68

 

Property and equipment purchased but not yet paid

 

$

 

 

$

35

 

Indemnification obligation for acquisition of business and intangible assets

 

$

 

 

$

300

 

Vendor credit received upon disposal of fixed asset

 

$

58

 

 

$

 

See accompanying notes to condensed consolidated financial statements.

5


 

Techpoint, Inc.

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Organization and Summary of Significant Accounting Policies

Organization

Techpoint, Inc. (together with its wholly-owned subsidiaries, the “Company”) was originally incorporated in California in April 2012 and reincorporated in Delaware in July 2017. The Company is a fabless semiconductor company that designs, markets and sells mixed-signal integrated circuits for multiple video applications in the automotive and security surveillance markets. The Company is headquartered in San Jose, California.

Basis of Consolidation and Significant Accounting Policies

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated. The functional currency of each of the Company’s subsidiaries is the U.S. dollar. Foreign currency gains or losses are recorded as other income (expense), net in the condensed consolidated statements of income and comprehensive income.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2023 contained in the Company’s Annual Report on Form 10-K.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods and are not necessarily indicative of the results to be expected for the full fiscal year or for any other future annual or interim periods.

Revenue Recognition

The Company principally sells its products to distributors who, in turn, sell to original equipment manufacturers (“OEM”), original design manufacturers (“ODM”), contract manufacturers, and design houses. Product revenue consists of sales of mixed-signal integrated circuits into the automotive and security surveillance markets. The Company generally requires advance payments from customers and records these advance payments, or contract liabilities, as customer deposits on its condensed consolidated balance sheet. No stock rotation, price protection or return rights are offered. The Company provides product assurance warranty only and does not offer warranties to be purchased separately. Revenue is recognized when control of the product is transferred to the Company's customers, upon shipment, whereby legal title, risks and rewards of ownership, and physical possession are transferred to the customer.

Use of Management’s Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Significant estimates included in the consolidated financial statements include inventory valuation and the valuation allowance for recorded deferred tax assets. These estimates are based upon information available as of the date of the condensed consolidated financial statements. Actual results could differ materially from those estimates.

 

6


 

Certain Significant Risks and Uncertainties

The Company operates in a dynamic industry and can be affected by a variety of factors. For example, any of the following areas could have a negative effect on the Company in terms of its future financial position, results of operations or cash flows: the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; successful and timely completion of product design efforts; trade restrictions by the United States against the Company's customers in China, or potential retaliatory trade actions taken by China; the loss of any of its larger customers; restrictions on the Company's ability to sell to foreign customers due to additional U.S. or new China trade laws, regulations and requirements; disruptions of the supply chain of components needed for its products; fundamental changes in the technology underlying the Company’s products; the hiring, training and retention of key employees; and new product design introductions by competitors.

The Company has been impacted by adverse macroeconomic and geopolitical conditions. These conditions include but are not limited to inflation, foreign currency fluctuations, and supply chain challenges. Management continues to actively monitor the impact of these conditions on the Company’s financial condition, liquidity, operations, end-customers (including its significant end-customers), distributors, suppliers, industry, and workforce. The extent to which such events impact the Company’s business, prospects and results of operations will depend on future developments, which are highly uncertain. The Company has made estimates of the impact of these events within its financial statements and there may be changes to those estimates in future periods.

Concentration of Customer and Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, and trade receivables. Risks associated with cash and cash equivalents, and investments are mitigated by banking with, and investing in, creditworthy institutions. The Company generally requires advance payments from customers. The Company also performs credit evaluations of its customers and provides credit to certain customers in the normal course of business. The Company has not incurred bad debt write-offs during any of the periods presented.

For each significant customer, or distributor, and significant end-customer, revenue as a percentage of total revenue was as follows:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Customer

 

 

 

 

 

 

 

 

 

 

 

Customer A

 

41

%

 

 

37

%

 

 

37

%

 

 

42

%

Customer B

*

 

 

 

11

%

 

 

10

%

 

 

10

%

End-Customer

 

 

 

 

 

 

 

 

 

 

 

End-Customer A (1)

 

26

%

 

 

24

%

 

 

21

%

 

 

25

%

 

* Less than 10%

(1)
Sales to End-Customer A primarily occurred through Customer A.

Concentration of Supplier Risk

The Company currently relies on Taiwan Semiconductor Manufacturing Company Limited and United Microelectronics Corporation (formerly Fujitsu Electronics America, Inc.) to produce substantially all of its semiconductors. Also, it relies on Advanced Semiconductor Engineering, Inc., Sigurd Microelectronics Corporation, ATX Semiconductor (Shanghai) Co., Ltd, and Chizhou Hisemi Electronics Technology Co., Ltd to assemble, package and test substantially all of its semiconductors to satisfy substantially all of the Company’s production requirements. The failure of any subcontractor to fulfill the production requirements of the Company on a timely basis would adversely impact future results. Although there are other subcontractors that are capable of providing similar services, an unexpected change in either subcontractor would cause delays in the Company’s products and potentially result in a significant loss of revenue.

Recently Issued Accounting Pronouncements Not Yet Adopted

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure. This guidance improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for the Company’s annual periods beginning January 1, 2024, and will become effective for interim periods within fiscal years beginning January 1, 2025. Retrospective application is required, with early

7


 

adoption permitted. The impact of this guidance is not expected to have any material impact on the disclosure of the Company’s consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to income tax disclosure. This guidance modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign operations) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign operations). This guidance also requires entities to disclose their income tax payments to international, federal and state and local jurisdictions. This guidance becomes effective for the Company’s annual periods beginning January 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company expects this guidance to only impact its disclosures and have no material impact on the Company’s consolidated financial statements.

 

2. Balance Sheet Components

Inventory

Inventory consists of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Work in process

 

$

9,138

 

 

$

4,795

 

Finished goods

 

 

4,516

 

 

 

4,723

 

Total inventory

 

$

13,654

 

 

$

9,518

 

Property and Equipment, net

Property and equipment, net consists of the following (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Machinery, computer equipment and software

 

$

2,687

 

 

$

2,759

 

Leasehold improvements

 

 

94

 

 

 

94

 

Furniture

 

 

38

 

 

 

36

 

Total property and equipment

 

 

2,819

 

 

 

2,889

 

Less: accumulated depreciation

 

 

(2,419

)

 

 

(2,367

)

Total property and equipment, net

 

$

400

 

 

$

522

 

 

The Company recorded $0.1 million of depreciation expense for each of the three months ended September 30, 2024 and 2023, and $0.2 million and $0.3 million for the nine months ended September 30, 2024 and 2023, respectively.

Goodwill and Intangible assets, net

Goodwill is tested for impairment annually as of December 31 or more frequently on a reporting unit basis when events or changes in circumstances indicate that impairment may have occurred. The Company is not aware of any events or circumstances indicating impairment of goodwill for the nine months ended September 30, 2024.

Changes in the carrying amount of goodwill for the nine months ended September 30, 2024 are as follows (in thousands):

 

 

 

 

 

Total

 

Goodwill at December 31, 2023

 

 

 

$

891

 

Adjustments

 

 

 

 

 

Goodwill at September 30, 2024

 

 

 

$

891

 

 

8


 

Intangible assets, except goodwill consist of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Acquired intellectual property

 

$

1,090

 

 

$

1,090

 

Less: accumulated amortization

 

 

(136

)

 

 

(54

)

Total finite-lived intangible assets, net

 

$

954

 

 

$

1,036

 

The amortization expenses of intangible assets were $81,000 and $27,000 for the nine months ended September 30, 2024 and 2023, respectively.

Acquired intellectual property is amortized over 10 years of its useful life. As of September 30, 2024, expected amortization expense for the unamortized finite-lived intangible assets by years is as follows (in thousands):

Year Ending December 31,

 

 

 

Amount

 

Remainder of 2024

 

 

 

$

28

 

2025

 

 

 

 

109

 

2026

 

 

 

 

109

 

2027

 

 

 

 

109

 

2028

 

 

 

 

109

 

Thereafter

 

 

 

 

490

 

Total

 

 

 

$

954

 

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Payroll-related expenses

 

$

2,401

 

 

$

983

 

Engineering service

 

 

791

 

 

 

199

 

Security for the indemnification obligations (1)

 

 

300

 

 

 

 

Accrued warranty

 

 

162

 

 

 

180

 

Accrued inventory

 

 

135

 

 

 

401

 

Professional fees

 

 

121

 

 

 

23

 

Taxes payable

 

 

95

 

 

 

468

 

Other

 

 

25

 

 

 

68

 

Total accrued liabilities

 

$

4,030

 

 

$

2,322

 

 

(1) In July 2023, the Company acquired certain assets of Broadvis Corporation, including intellectual property and $0.3 million that was retained by the Company at closing as security for the indemnification obligations of Broadvis Corporation is expected to be released in January 2025, barring unforeseen circumstances.

Customer Deposits

Customer deposits represent payments received in advance of shipments and fluctuate depending on timing of customer pre-payments and product shipment. Customer deposits were $2.0 million, $0.8 million, and $1.4 million as of September 30, 2024, June 30, 2024, and December 31, 2023, respectively. The Company generally expects to recognize revenue from customer deposits during the three month period immediately following the balance sheet date. The Company recognized $0.8 million of revenue from the June 30, 2024 customer deposit balance during the three months ended September 30, 2024, and $1.4 million of revenue from the December 31, 2023 customer deposits balance during the three months ended March 31, 2024.

 

9


 

3. Fair Value Measurements of Financial Instruments

Summary of Financial Instruments

The following is a summary of financial instruments (in thousands):

 

 

 

 

 

 

September 30, 2024

 

 

 

Amortized Cost

 

 

Gross Unrealized Gain

 

 

Gross Unrealized Loss

 

 

Estimated Fair Values

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

$

457

 

 

$

 

 

$

 

 

$

457

 

U.S.Treasury bills and notes

 

 

17,251

 

 

54

 

 

 

 

 

 

17,305

 

Government agency bonds

 

 

525

 

 

 

 

 

 

 

 

 

525

 

Corporate bonds

 

 

3,998

 

 

 

 

 

 

(2

)

 

 

3,996

 

Total available-for-sale securities

 

$

22,231

 

 

$

54

 

 

$

(2

)

 

$

22,283

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

$

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

22,283

 

Long-term investments

 

 

 

 

 

 

 

 

 

 

 

 

Total available-for-sale securities

 

 

 

 

 

 

 

 

 

 

$

22,283

 

 

 

 

 

 

 

 

December 31, 2023

 

 

 

Amortized Cost

 

 

Gross Unrealized Gain

 

 

Gross Unrealized Loss

 

 

Estimated Fair Values

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

$

3,633

 

 

$

1

 

 

$

 

 

$

3,634

 

U.S.Treasury bills and notes

 

 

37,624

 

 

76

 

 

 

 

 

 

37,700

 

Government agency bonds

 

 

2,600

 

 

 

 

 

 

(3

)

 

 

2,597

 

Corporate bonds

 

 

11,504

 

 

 

 

 

 

(51

)

 

 

11,453

 

Total available-for-sale securities

 

$

55,361

 

 

$

77

 

 

$

(54

)

 

$

55,384

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

$

3,096

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

51,788

 

Long-term investments

 

 

 

 

 

 

 

 

 

 

 

500

 

Total available-for-sale securities

 

 

 

 

 

 

 

 

 

 

$

55,384

 

The contractual maturities of available-for-sale securities are presented in the following table (in thousands):

 

 

 

 

 

 

 

September 30,2024

 

 

December 31, 2023

 

 

Amortized Cost

 

 

Estimated Fair Value

 

 

Amortized Cost

 

 

Estimated Fair Value

 

Due in one year or less

$

22,231

 

 

$

22,283

 

 

$

54,859

 

 

$

54,884

 

Due between one to two years

 

 

 

 

 

 

 

502

 

 

 

500

 

 

$

22,231

 

 

$

22,283

 

 

$

55,361

 

 

$

55,384

 

The Company had 12 investments in unrealized loss positions as of September 30, 2024. Five of such investments have been in unrealized loss positions for less than twelve months. The total Fair Value of such investments is $7.3 million with no material unrealized losses as of September 30, 2024. There were no material gross unrealized losses from available-for-sale securities and no material realized gains or losses from available-for-sale securities that were reclassified from accumulated other comprehensive income for the nine months ended September 30, 2024.

For investments in available-for-sale debt securities that have unrealized losses, the Company evaluates (i) whether it has the intention to sell any of these investments and (ii) whether it is more likely than not that it will be required to sell any of these investments before recovery of the entire amortized cost basis. Based on this evaluation, the Company determined that there were no other-than-temporary impairments associated with investments as of September 30, 2024.

10


 

There were no sales of available-for-sale securities for the nine months ended September 30, 2024 and 2023.

Fair Value Measurements

Fair value is defined as the exchange price that would be received from selling an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company measures financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:

Level 1. Quoted prices in active markets for identical assets or liabilities.

Level 2. Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3. Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

Financial assets measured at fair value on a recurring basis were as follows (in thousands):

 

 

Fair Value Measurement at Reporting Date Using

 

 

Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Total

 

As of September 30, 2024

 

 

 

 

 

 

 

 

Financial assets - available-for-sale securities

 

 

 

 

 

 

 

 

   Certificates of deposit

$

 

 

$

457

 

 

$

457

 

   U.S.Treasury bills and notes

 

 

 

 

17,305

 

 

 

17,305

 

   Governmental agency bonds

 

 

 

 

525

 

 

 

525

 

   Corporate bonds

 

3,996

 

 

 

 

 

 

3,996

 

Total financial assets - available-for-sale securities

$

3,996

 

 

$

18,287

 

 

$

22,283

 

 

 

 

 

 

 

 

 

As of December 31, 2023

 

 

 

 

 

 

 

 

Financial assets - available-for-sale securities

 

 

 

 

 

 

 

 

   Certificates of deposit

$

 

 

$

3,634

 

 

$

3,634

 

   U.S.Treasury bills and notes

 

2,198

 

 

 

35,502

 

 

 

37,700

 

   Governmental agency bonds

 

600

 

 

 

1,997

 

 

 

2,597

 

   Corporate bonds

 

10,953

 

 

 

500

 

 

 

11,453

 

Total financial assets - available-for-sale securities

$

13,751

 

 

$

41,633

 

 

$

55,384

 

The Company uses a pricing service to assist in determining the fair values of all of its cash equivalents, short-term investments and long-term investments. The pricing service uses inputs from multiple industry standard data providers or other third party sources and applies various acceptable methodologies.

 

 

 

 

 

 

 

 

 

 

 

11


 

 

4. Segment Information

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

The Company’s chief operating decision maker, the chief executive officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance on a regular basis. Accordingly, the Company considers itself to be one reportable segment, which is comprised of one operating segment - the designing, marketing and selling of mixed-signal integrated circuits for the automotive and security surveillance markets.

Product revenue from customers is designated based on the geographic region to which the product is delivered. Revenue by geographic region was as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

China

 

$

13,299

 

 

$

13,084

 

 

$

37,936

 

 

$

34,836

 

Taiwan

 

 

2,653

 

 

 

2,293

 

 

 

7,438

 

 

 

6,355

 

South Korea

 

 

1,556

 

 

 

1,466

 

 

 

3,938

 

 

 

4,229

 

Japan

 

 

384

 

 

 

339

 

 

 

746

 

 

 

1,046

 

Other

 

 

594

 

 

 

329

 

 

 

1,518

 

 

 

485

 

Total revenue

 

$

18,486

 

 

$

17,511

 

 

$

51,576

 

 

$

46,951

 

Revenue by principal product lines was as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Automotive

 

$

12,771

 

 

$

12,467

 

 

$

37,638

 

 

$

31,194

 

Security surveillance

 

 

5,715

 

 

 

5,044

 

 

 

13,938

 

 

 

15,757

 

Total revenue

 

$

18,486

 

 

$

17,511

 

 

$

51,576

 

 

$

46,951

 

Long-lived assets by geographic region were as follows (in thousands):

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Taiwan

 

$

239

 

 

$

308

 

China

 

 

101

 

 

 

176

 

United States

 

 

51

 

 

 

29

 

South Korea

 

 

7

 

 

 

6

 

Japan

 

 

2

 

 

 

3

 

Total property and equipment, net

 

$

400

 

 

$

522

 

 

 

12


 

 

5. Commitments and Contingencies

Operating leases

The Company determines if an arrangement contains a lease at inception. The Company leases facilities under non-cancelable lease agreements expiring through fiscal year 2026. The Company’s agreements do not include variable lease payments or any restrictions or covenants imposed by the leases. As the rate implicit in each lease agreement is not readily determinable, the Company’s incremental borrowing rate was used as the discount rate. The Company’s right-of-use assets and lease liabilities have been adjusted for initial direct costs and prepaid rent but do not reflect any options to extend or terminate its lease agreements, any residual value guarantees, or any leases that have not yet commenced.

The right-of-use assets and lease liabilities related to operating leases were as follows (in thousands):

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Right-of-use assets

 

$

1,152

 

 

$

1,045

 

 

 

 

 

 

 

 

Lease liabilities - Current

 

$

675

 

 

$

497

 

Lease liabilities - Non-Current

 

 

517

 

 

 

531

 

Total lease liabilities

 

$

1,192

 

 

$

1,028

 

Rent expense under operating leases was $0.2 million for each of the three months ended September 30, 2024 and 2023. Rent expense under operating leases was $0.6 million for each of the nine months ended September 30, 2024 and 2023.

The rent expense recognized from short-term leases was $6,000 for each of the three months ended September 30, 2024 and 2023, respectively. The rent expense recognized from short-term leases was $18,000 for each of the nine months ended September 30, 2024 and 2023.

The following tables summarize the Company’s lease costs and weighted-average assumptions used in determining its right-of-use assets and lease liabilities (in thousands):

 

 

Nine Months Ended

 

 

 

September 30,

 

 

 

2024

 

 

2023

 

Operating lease cost

 

$

582

 

 

$

578

 

Cash paid for operating leases

 

$

547

 

 

$

589

 

Right-of-use assets obtained in exchange for operating lease liabilities (1)

 

$

651

 

 

$

68

 

Weighted average remaining term for operating leases

 

1.74 years

 

 

0.71 years

 

Weighted average discount rate for operating leases

 

 

8.2

%

 

 

5.7

%

 

(1) During the nine months ended September 30, 2024, the Company extended the terms of its leases in Taiwan, Japan and two China offices; all of the extensions were treated as modifications but not as separate contracts, as no additional right-of-use was granted. These lease modifications were accounted for as non-cash changes in existing lease liabilities and the right-of-use assets.


During the nine months ended September 30, 2023, the Company extended the term of its lease in South Korea; the South Korea lease was treated as a modification but not as a separate contract, as no additional right-of-use was granted. The South Korea lease modification was accounted for as a non-cash change in existing lease liabilities and the right-of-use assets. In addition, the Company entered into
two lease agreements for two new offices in China, and additional right-of-use was granted.

 

 

13


 

As of September 30, 2024, the aggregate future minimum lease payments under non-cancelable operating leases consist of the following (in thousands):

Year Ending December 31,

 

Amount

 

2024 (remaining three months)

 

$

193

 

2025

 

 

728

 

2026

 

 

349

 

Total

 

 

1,270

 

Less effects of discounting

 

 

(78

)

Total lease liabilities

 

$

1,192

 

Purchase Commitments

As of September 30, 2024, the Company had purchase commitments with its third-party suppliers through fiscal year 2026. Future minimum payments under purchase commitments total $0.5 million for the remaining three months ending December 31, 2024, $0.7 million for the year ending December 31, 2025, and $0.3 million for the year ending December 31, 2026.

Litigation

Although the Company is not currently a party to any legal proceedings and there is no litigation currently threatened, the Company may be subject to legal proceedings, claims and litigation, including intellectual property litigation, arising in the ordinary course of business. Such matters are subject to many uncertainties and outcomes and are not predictable with assurance. The Company accrues amounts that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss that is reasonably estimable.

Indemnification

During the normal course of business, the Company may make certain indemnities, commitments and guarantees which may include intellectual property indemnities to certain of its customers in connection with the sales of the Company’s products and indemnities for liabilities associated with the infringement of other parties’ technology based upon the Company’s products. The Company’s exposure under these indemnification provisions is generally limited to the total amount paid by a customer under the agreement. However, certain agreements include indemnification provisions that could potentially expose the Company to losses in excess of the amount received under the agreement. In addition, the Company indemnifies its officers, directors and certain key employees while they are serving in good faith in such capacities.

The Company has not recorded any liability for these indemnities, commitments and guarantees in the accompanying condensed consolidated balance sheets. Where necessary, the Company accrues for losses for any known contingent liabilities, including those that may arise from indemnification provisions, when future payment is probable.

14


 

6. Stockholders’ Equity

Preferred Stock

The Company is authorized to issue 5,000,000 shares of preferred stock with a $0.0001 par value per share as of September 30, 2024 and December 31, 2023. There were no shares of preferred stock issued and outstanding as of September 30, 2024 and December 31, 2023.

Common Stock

The Company is authorized to issue 75,000,000 shares of common stock with $0.0001 par value per share as of September 30, 2024 and December 31, 2023. As of September 30, 2024, the shares of common stock issued and outstanding totaled 18,585,141. As of December 31, 2023, the shares of common stock issued and outstanding were 18,395,682.

The Company has reserved the following number of shares of common stock for future issuances:

 

 

 

 

 

 

September 30, 2024

 

Outstanding stock awards

 

 

971,031

 

Shares available for future issuance under the 2017 Stock Incentive Plan

 

 

6,948,562

 

Total common stock reserved for future issuances

 

 

7,919,593

 

Dividend

On December 15, 2023, the Company announced a cash dividend of an aggregate of $0.50 per share for fiscal year 2024, payable in two equal installments of $0.25 per share. The first installment of the dividend was paid during the first fiscal quarter of 2024 in the aggregate amount of $4.6 million to stockholders of record as of the close of business on January 31, 2024. On May 31, 2024, the Company announced that the second installment payment of its cash dividend of $0.25 on shares of its common stock (including common stock underlying its Japanese Depositary Shares ("JDS")), which was paid to stockholders of record as of June 28, 2024 on July 18, 2024. The aggregate amount of the two dividend payments was $9.2 million.

On December 16, 2022, the Company announced a cash dividend of an aggregate of $0.50 per share for fiscal year 2023, payable in two equal installments of $0.25 per share. The first installment of the dividend was paid during the first fiscal quarter of 2023 in the aggregate amount of $4.6 million to stockholders of record as of the close of business on January 31, 2023. On June 2, 2023, the Company announced that the second installment payment of its cash dividend of $0.25 on shares of its common stock (including common stock underlying its JDS), which was paid to stockholders of record as of June 30, 2023 on July 18, 2023. The aggregate amount of the two dividend payments was $9.1 million.

 

7. Equity Incentive Plans

Stock Incentive Plans

In April 2012, the Company adopted a 2012 Stock Option Plan (“2012 Plan”). The 2012 Plan provides for the granting of stock-based awards to employees, directors, and consultants under terms and provisions established by the Company’s board of directors. Under the terms of the 2012 Plan, options may be granted at an exercise price not less than fair market value. For employees holding more than 10% of the voting rights of all classes of stock, the exercise prices for incentive and non-statutory stock options must be at least 110% of the fair market value of the common stock on the grant date, as determined by the Company’s board of directors. The terms of options granted under the 2012 Plan may not exceed ten years.

The 2012 Plan was superseded by a 2017 Stock Option Plan (“2017 Plan”). Any outstanding awards under the 2012 Plan will continue to be governed by the terms of the 2012 Plan.

15


 

In August 2017, the Company adopted the 2017 Plan. The Company’s stockholders approved the 2017 Plan in September 2017 and it became effective immediately prior to the closing of the Company’s initial public offering. In connection with the adoption of the 2017 Plan, no additional awards and no shares of common stock remain available for future issuance under the 2012 Plan and shares reserved but not issued under the 2012 Plan as of the effective date of the 2017 Plan were included in the number of shares reserved for issuance under the 2017 Plan. In addition, shares subject to awards under the 2012 Plan that are forfeited or terminated are added to the 2017 Plan. The number of shares available for issuance under the 2017 Plan can be automatically increased on the first day of each fiscal year beginning on January 1, 2018 and ending on (and including) January 1, 2027, in an amount equal to the lesser of (1) 4% of the outstanding shares of the Company’s common stock on the last day of the immediately preceding fiscal year, or (2) another amount determined by the Company’s board of directors. The 2017 Plan provides for the granting of incentive stock options within the meaning of Section 422 of the Internal Revenue Code to employees and the granting of non-statutory stock options to employees, non-employee directors, advisors and consultants. The 2017 Plan also provides for the grants of restricted stock, stock appreciation rights, stock unit and cash-based awards to employees, non-employee directors, advisors and consultants.

 

On November 7, 2023, the board of directors of the Company determined not to increase the number of shares of the Company’s common stock authorized for issuance under its 2017 Plan for the 2024 fiscal year, which would have been otherwise subject to a four percent (4%) annual increase on January 1, 2024.

The Company’s stock award activity under the 2017 Plan is summarized as follows:

 

 

Awards Available for
Grant

 

As of December 31, 2023

 

 

7,057,446

 

Authorized

 

 

 

Granted

 

 

(140,000

)

Canceled

 

 

31,116

 

As of September 30, 2024

 

 

6,948,562

 

Stock Options

The Company’s stock option activity under the 2017 Plan is summarized as follows:

 

 

Options
Issued and
Outstanding

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

As of December 31, 2023

 

 

431,081

 

 

$

2.81

 

 

 

3.3

 

 

$

3,305

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(39,400

)

 

 

2.66

 

 

 

 

 

 

 

Canceled

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2024

 

 

391,681

 

 

 

2.82

 

 

 

2.5

 

 

 

2,314

 

Options vested and exercisable as of September 30, 2024

 

 

391,681

 

 

 

2.82

 

 

 

2.5

 

 

 

2,314

 

 

 

 

16


 

The stock options outstanding and exercisable by exercise price as of September 30, 2024 are as follows:

 

 

 

Options Outstanding, Vested and Exercisable

 

Exercise Price

 

 

Number
Outstanding

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

 

Weighted-
Average
Exercise
Price

 

$

0.37

 

 

 

10,000

 

 

 

1.1

 

 

$

0.37

 

 

0.97

 

 

 

8,000

 

 

 

1.4

 

 

 

0.97

 

 

2.51

 

 

 

46,780

 

 

 

2.2

 

 

 

2.51

 

 

2.89

 

 

 

30,000

 

 

 

3.6

 

 

 

2.89

 

 

2.93

 

 

 

218,734

 

 

 

3.0

 

 

 

2.93

 

 

3.18

 

 

 

78,167

 

 

 

3.1

 

 

 

3.18

 

 

 

 

391,681

 

 

 

2.9

 

 

 

2.82

 

 

The aggregate intrinsic value of options exercised for the nine months ended September 30, 2024 and 2023 was $0.3 million and $0.2 million, respectively. The Company has various vesting agreements with its employees. Options granted generally vest over a five-year period and generally are exercisable for up to 10 years.

 

Restricted Stock Units

The Company’s restricted stock units activity under the 2017 Plan is summarized as follows:

 

 

Units
Issued and
Outstanding

 

 

Weighted-Average
Grant Date
Fair Value

 

As of December 31, 2023

 

 

620,525

 

 

$

7.63

 

Granted

 

 

140,000

 

 

 

8.48

 

Released, net of shares withheld for tax withholdings

 

 

(150,059

)

 

 

7.55

 

Canceled

 

 

(31,116

)

 

 

8.11

 

As of September 30, 2024

 

 

579,350

 

 

 

7.83

 

Restricted stock units are converted into shares of the Company’s common stock upon vesting on a one-for-one basis. Restricted stock unit awards generally vest over a five-year period and are subject to the grantee’s continued service with the Company.

8. Stock-Based Compensation

The following table summarizes the distribution of stock-based compensation expense by line item in the condensed consolidated statements of income and comprehensive income (in thousands):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

$

29

 

 

$

34

 

 

$

86

 

 

$

110

 

Research and development

 

157

 

 

 

166

 

 

 

457

 

 

 

400

 

Selling, general and administrative

 

214

 

 

 

206

 

 

 

651

 

 

 

626

 

Total

$

400

 

 

$

406

 

 

$

1,194

 

 

$

1,136

 

 

17


 

9. Net Income Per Share

The following table presents the calculation of basic and diluted net income per share (amounts in thousands, except share and per share data):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted:

 

 

 

 

 

 

 

 

 

 

 

Net income

$

5,052

 

 

$

5,195

 

 

$

13,768

 

 

$

12,621

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Basic shares:

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding used in computing basic
   net income per share

 

18,571,666

 

 

 

18,353,552

 

 

 

18,492,688

 

 

 

18,293,535

 

Diluted shares:

 

 

 

 

 

 

 

 

 

 

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

Stock options and restricted stock units

 

360,685

 

 

 

294,257

 

 

 

425,493

 

 

 

315,238

 

Weighted-average shares used in computing diluted net
   income per share

 

18,932,351

 

 

 

18,647,809

 

 

 

18,918,181

 

 

 

18,608,773

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.27

 

 

$

0.28

 

 

$

0.74

 

 

$

0.69

 

Diluted

$

0.27

 

 

$

0.28

 

 

$

0.73

 

 

$

0.68

 

The potentially dilutive shares of common stock outstanding for the three months ended September 30, 2024 and 2023 that were excluded from the computation of diluted net income per share as the effect would have been antidilutive, was approximately 138,000 and 262,000 shares, respectively. The potentially dilutive shares of common stock outstanding for the nine months ended September 30, 2024 and 2023 that were excluded from the computation of diluted net income per share for the periods presented as the effect would have been antidilutive was 90,000 and 255,000 shares, respectively.

10. Provision for Income Taxes

The components of income before income taxes were as follows (in thousands):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Domestic

$

5,513

 

 

$

5,798

 

 

$

15,275

 

 

$

14,119

 

Foreign

 

207

 

 

 

62

 

 

 

339

 

 

 

131

 

Income before income taxes

$

5,720

 

 

$

5,860

 

 

$

15,614

 

 

$

14,250

 

The components of the provision for income taxes were as follows (in thousands):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

United States

$

646

 

 

$

658

 

 

$

1,805

 

 

$

1,614

 

Foreign

 

22

 

 

 

7

 

 

 

41

 

 

 

15

 

Provision for income taxes

$

668

 

 

$

665

 

 

$

1,846

 

 

$

1,629

 

The Company applies the provisions of the applicable accounting guidance regarding accounting for uncertainty in income taxes, which require application of a more-likely-than-not threshold to the recognition and derecognition of uncertain tax positions. If the recognition threshold is met, the applicable accounting guidance permits the recognition of a tax benefit measured at the largest amount of such tax benefit that, in the Company’s judgment, is more than fifty percent likely to be realized upon settlement. It further requires that a change in judgment related to the expected ultimate resolution of uncertain tax positions to be recognized in earnings in the period in which such determination is made. The Company will continue to review its tax positions and provide for, or reverse, unrecognized tax benefits as issues arise.

As of September 30, 2024, there was no material increase in the liability for unrecognized tax benefits and no accrued interest or penalties related to uncertain tax positions.

18


 

As of September 30, 2024, the Company had approximately $0.4 million of unrecognized tax benefits of which $0.3 million was netted against deferred tax assets with a full valuation allowance. If these amounts are recognized, there will be a tax benefit of $0.1 million against the Company’s effective tax rate.

The Company files income tax returns in the U.S. federal, California, and foreign jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations for years prior to 2020 for federal purposes and 2019 for state purposes, except in certain limited circumstances. In California, the Company's net operating loss (“NOL”) and credit carryforwards from all years may be subject to adjustment for four years for California following the year in which utilized. Currently, the Company has California NOLs and credit carryforwards from 2012 which remain subject to adjustment for four years following the year in which utilized, and therefore tax years 2012 through 2023 may remain open for state audit. The Company does not anticipate that any potential tax adjustments will have a significant impact on its financial position or results of operations.

The CHIPS and Science Act of 2022 ("CHIPS") and the Inflation Reduction Act ("IRA") of 2022 were signed into law by President Biden on August 9, 2022 and August 16, 2022, respectively. The legislation introduces new options for monetizing certain credits, a corporate alternative minimum tax, and a stock repurchase excise tax. The Company has concluded that the impact of any of the provisions included in CHIPS and IRA acts did not have a material impact on the Company's unaudited condensed consolidated financial statements as of and for the nine months ended September 30, 2024.

 

19


 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Information Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, strategy and plans, our expectations for future operations, expectations regarding adoption of accounting pronouncements, our belief regarding adequacy of accruals related to future litigation, and expectations related to indemnities, are forward-looking statements. The words “anticipate”, “believe,” “continue,” “could,” “design,” “estimate,” “intend,” “may,” “plan,” “project,” “will,” “expect,” or the negative version of these words and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the following:

our future financial performance, including our revenue, sales, cost of sales and operating expenses;
our market opportunity and our ability to effectively manage or sustain our growth;
our ability to attract new and retain existing customers in our current or future target markets;
our ability to continue to develop new technologies and secure design wins;
our ability to achieve the expected benefits from our acquisitions;
laws and regulations applicable to our business, including the expected impact of restrictions to be imposed by trade regulations;
the impact of global shortages in manufacturing capacities;
our ability to form and expand partnerships with technology partners and consulting partners;
our ability to maintain, protect and enhance our intellectual property;
our ability to successfully defend litigation brought against us;
our product development and sales cycle;
the strength of our competition;
the impact of macroeconomic conditions, including inflation, recession and trade relations between the U.S. and China, on our business;
the effect of health epidemics on our business and the success of any measures we have taken or may take in the future in response thereto;
the impact of potential tax adjustments;
our liquidity and working capital requirements; and
our expectations regarding future expenses and investments.

 

In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Quarterly Report on Form 10-Q may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Any forward-looking statement made by us in this Quarterly Report on Form 10-Q is as of the date on which it is filed with the SEC. We do not intend to update any of these forward-looking statements after the date of this Quarterly Report on Form 10-Q, except as required by law.

General Background

The following discussion and analysis should be read together with our unaudited condensed consolidated financial statements and the notes to those statements that appear in this Quarterly Report on Form 10-Q and our consolidated financial statements and the notes to those statements that appear in our Annual Report on Form 10-K for the year ended December 31, 2023. This discussion contains forward-looking statements based on our current expectations, assumptions, estimates and projections. These

20


 

forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those indicated in these forward-looking statements as a result of certain factors, as more fully described in “Risk Factors” in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K.

In this Quarterly Report on Form 10-Q, unless otherwise specified or the context otherwise requires, “Techpoint,” “we,” “us,” and “our” refer to Techpoint, Inc. and its consolidated subsidiaries.

We have obtained or are in the process of obtaining registered trademarks for Techpoint and HD-TVI. This Quarterly Report on Form 10-Q contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report, including logos, artwork and other visual displays, may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies’ trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Overview

We are a fabless semiconductor company that designs, markets and sells mixed-signal integrated circuits for multiple video applications in the automotive and security surveillance markets. Our integrated circuits are enabling the transition from standard definition (“SD”) video to high definition (“HD”) video in the automotive and security surveillance markets.

Our solutions take HD video signals from a camera and convert them into analog signals for reliable long-distance transmission, then convert the HD analog signal into the appropriate format for video processing and display. Our HD analog technology operates at the same 1080p HD resolution as digital HD, but processes video in an HD analog format and transmits the video in this same analog format, thereby eliminating the need for any compression or decompression. Our integrated circuits are based on our proprietary architecture and mixed signal technologies that we believe provide high video quality, enable high levels of integration and are cost effective.

We derive our revenue from sales of our mixed-signal integrated circuits into the automotive and security surveillance markets. We began shipping our products in 2013 and to date, we have sold over 475 million integrated circuits. Our revenue was $51.6 million and $47.0 million for the nine months ended September 30, 2024 and 2023, respectively. The automotive market accounted for 73% and 66% of our revenue for the nine months ended September 30, 2024 and 2023, respectively. The security surveillance market accounted for 27% and 34% of our revenue for the nine months ended September 30, 2024 and 2023, respectively. We recognized $37.6 million and $31.2 million of revenue on sales into the automotive market for the nine months ended September 30, 2024 and 2023, respectively. In addition, we recognized $14.0 million and $15.8 million of revenue on sales into the security surveillance market for the nine months ended September 30, 2024 and 2023, respectively. We recorded net income of $13.8 million and $12.6 million for the nine months ended September 30, 2024 and 2023, respectively.

We sell our products to distributors that fulfill third-party orders for our products. We also sell directly to OEM and ODM. For the nine months ended September 30, 2024 and 2023, we derived substantially all of our revenue from products sold to distributors as compared to products sold to OEM and ODM directly.

We undertake significant product development efforts well in advance of a product’s release and in advance of receiving purchase orders. Our product development efforts, which are focused on developing new designs with broad demand and potential for future derivative products, typically take from six to twenty-four months until production begins, depending on the product’s complexity. If we secure a design win, we believe the system designer is likely to continue to use the same or enhanced versions of our product across a number of their models, extending the life cycles of our products. Conversely, if a competitor secures the design win, it may be difficult for us to sell into the end-customer’s application for an extended period. Our sales cycle typically ranges from one to three years for the automotive market and three to six months for the security surveillance market. Due to the length of our product development and sales cycle, the majority of our revenue for any period is likely to be weighted toward products introduced for sale in the prior one or two years. As a result, our present revenue is not necessarily representative of future sales because our future sales are likely to be comprised of a different mix of products, some of which are now in the development stage.

We employ a fabless manufacturing strategy and use market-leading suppliers for all phases of the manufacturing process, including wafer fabrication, assembly, testing and packaging. This strategy significantly reduces the capital investment that would otherwise be required to operate manufacturing facilities of our own.

We have made significant investments in research and development in order to develop our products to attract and retain end-customers. For the nine months ended September 30, 2024 and 2023, our research and development expense was $6.5 million and $5.3 million, respectively. Our research and development expenses can vary from period-to-period and can be significantly impacted

21


 

by the number of tape-outs and new products that we initiate in any given period. As of September 30, 2024, we had 103 employees, 39 of whom are in research and development. Our headquarters are located in San Jose, California, with additional operations in Japan, Taiwan, China and South Korea.

Effective October 9, 2019, the U.S. Commerce Department’s Bureau of Industry and Security (“BIS”) added Hikvision, a customer that represented 21% and 25% of our revenue for the nine months ended September 30, 2024 and 2023, respectively, to the BIS Entity List with a license requirement for all items subject to the Export Administration Regulations (“EAR”). The BIS Entity List is a published list of the names of certain foreign persons, including businesses, research institutions, government and private organizations and individuals, that are subject to specific governmental license requirements for the export, reexport and/or transfer of specified items. These license requirements could make it more difficult to ship, or in some cases, prevent the shipment of products to certain foreign persons named on the BIS Entity List.

We have taken action to confirm whether our products are subject to EAR. We have retained the continuous assistance of outside experts and, following Hikvision’s designation on the BIS Entity List, performed a comprehensive review of our products and manufacturing operations. Based on that review, we concluded that our products are not subject to EAR. Therefore, our products may continue to be shipped to Hikvision without a U.S. export license, even though Hikvision appears on the BIS Entity List.

On November 12, 2020, President Trump issued Executive Order 13959 on Addressing the Threat from Securities Investments that Finance Communist Chinese Military Companies which prohibits any transaction in publicly traded securities, or any securities that are derivative of, or are designed to provide investment exposure to such securities, of any identified Communist Chinese military company, which included Hikvision. On June 3, 2021, President Biden issued Executive Order 14032 amending the prior Executive Order. As amended, Executive Order 13959 continues to prohibit certain transactions involving the purchase or sale of publicly traded securities of designated companies. Restrictions are applicable to certain entities designated as Chinese Military-Industrial Complex Companies who have been placed on the “CMIC List.” Hikvision was listed in the Annex to Executive Order 14032 and is currently on the CMIC List. However, Hikvision is not on the Specially Designated Nationals (SDN) List and the restrictions imposed by these Executive Orders are not expected to directly impact our business.

On November 11, 2021, President Biden signed into law the Secure Equipment Act of 2021, pursuant to which the U.S. Federal Communications Commission (“FCC”) adopted rules on November 11, 2022 clarifying that it will no longer review or approve any application for equipment authorization for equipment that is on the list of covered communications equipment or services published by the FCC under section 2(a) of the Secure and Trusted Communications Networks Act of 2019. Items on the FCC’s “covered list” include video surveillance and telecommunications equipment produced by Hikvision, to the extent it is used for the purpose of public safety, security of government facilities, physical security surveillance of critical infrastructure, and other national security purposes, including telecommunications or video surveillance services provided by such entity or using such equipment. The restrictions imposed by the FCC pursuant to the Secure Equipment Act of 2021 impact imports of certain Hikvision equipment into the United States by eliminating the ability of Hikvision to obtain FCC approval for its video surveillance and telecommunications equipment. In a pending rulemaking proceeding, the FCC is considering the adoption of new rules to revoke past authorization issued for Hikvision equipment, but the FCC actions taken to date are currently not expected to directly impact our business. This may or may not directly impact our revenue in the future. In the event there is an impact on our revenue, we believe that it would be gradual and limited in scope both because Hikvision continues to sell its currently approved products in the U.S. and because other manufacturers that incorporate our products could take market share from Hikvision in the U.S. We believe that our revenue would decrease only a few percentage points even if Hikvision’s business is fully impacted by the restrictions to be imposed by the FCC that limit Hikvision’s ability to import its future products into the U.S. Additionally, we plan to continue growing our revenue from new and existing customers, thus further limiting the impact of the restrictions to be imposed by the FCC that impact the importation of certain of Hikvision’s future products into the U.S.

The above conclusions are as of the date of filing of this Quarterly Report on Form 10-Q. It is possible that changes in U.S. regulations or policies in the future may impose restrictions, including the imposition of license requirements or even a full or partial prohibition, on our sale of products to Hikvision.

Key Factors Affecting Our Results of Operations

The following are key factors that impact our results of operations:

Macroeconomic and Geopolitical Conditions. We have been impacted by adverse macroeconomic and geopolitical conditions. These conditions include but are not limited to inflation, foreign currency fluctuations, and supply chain challenges. Management continues to actively monitor the impact of these conditions on the Company’s financial condition, liquidity, operations, end-customers (including its significant end-customers), distributors, suppliers, industry, and workforce. The extent to which such events impact the Company’s business, prospects and results of operations will depend on future developments, which are highly uncertain.

22


 

Ability to attract and retain customers that make large orders. While we expect the composition of our end-customers to change over time, our business and operating results depend on our ability to continually target new and retain existing end-customers that make large orders. Hikvision, the largest security surveillance manufacturer in China, is one of our significant end-customers, as previously noted. Although large customers can help us increase our revenue and improve our results of operations, reliance on large customers is a risk to our business. For example, Section 889 of the 2019 National Defense Authorization Act could adversely impact our business with Hikvision. Section 889(a)(1)(A) went into effect on August 13, 2019 and prohibits U.S. government agencies from procuring or obtaining equipment or services that use covered telecommunications equipment or services as a substantial or essential component or critical technology, including certain video surveillance products or telecommunications equipment and services produced or provided by Hikvision. On July 14, 2020, the U.S. government issued an interim final rule that implements Section 889(a)(1)(B) effective as of August 13, 2020. This rule prohibits the U.S. government from entering into contracts with persons who use covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system, which again includes certain of Hikvision’s video surveillance products. Although Section 889 does not prohibit commercial sales of video surveillance products by Hikvision in the U.S., which we understand is the predominant business Hikvision does in the U.S. with video surveillance products that incorporate our products, the impact of these new regulations and the uncertainty of U.S. and China trade relations may adversely impact our business in the future with Hikvision and other significant customers.

Design wins with new and existing customers. We believe our products provide high-quality HD video with an attractive combination of characteristics, at a lower overall cost than competing solutions. In order to get our solutions designed into our end-customer’s products, we work with our end-customers and potential end-customers to understand their product roadmaps and strategies. We consider design wins to be critical to our future success. We define a design win as the successful completion of the evaluation stage, where an end-customer has tested our product, verified that our product meets its requirements and qualified our integrated circuits for their products. We have secured design wins with major automotive manufacturers to sell our solutions to them for automotive backup cameras. The revenue that we generate, if any, from each design win can vary significantly. Our long-term sales expectations are based on forecasts from end-customers, internal estimates of end-customer demand factoring in expected time to market for end-customer products incorporating our solutions and associated revenue potential and internal estimates of overall demand based on historical trends.

Pricing, product cost and gross margins of our products. Our gross margin has been and will continue to be affected by a variety of factors, including the timing of changes in pricing, shipment volumes, new product introductions, changes in product mixes, changes in our purchase price of fabricated wafers and assembly and test service costs, manufacturing yields and inventory write downs, if any. In general, newly introduced products and products with higher performance and more features tend to be priced higher than older, more mature products. Average selling prices in the semiconductor industry typically decline as products mature. Consistent with the historical trend, we expect that the average selling prices of our products will, in the longer term, decline as our product lines mature. In the normal course of business, we will seek to offset the effect of declining average selling prices on existing products by reducing manufacturing costs and introducing new and higher value-added products. If we are unable to maintain overall average selling prices or offset any declines in average selling prices with realized savings on product costs, our gross margin will decline.

Product adoption and safety regulations in the automotive market. We have secured design wins with major automotive equipment manufacturers to sell our solutions to them for automotive backup cameras. Certain jurisdictions have passed laws and regulations requiring that all new cars sold after a certain date must contain back-up cameras, including with respect to cars sold in the United States after May 2018. If these jurisdictions do not maintain and implement these rules, or if back-up cameras are not put into automobiles sold in other locations as well, or do so more slowly than we expect, our financial results could be adversely affected.

Investment in growth. We have invested, and intend to continue to invest, in expanding our operations, increasing our headcount, developing our products and differentiated technologies to support our growth and expanding our infrastructure. We expect our total operating expenses to increase significantly in the foreseeable future to meet our growth objectives. We plan to continue to invest in our sales and support operations throughout the world, with a particular focus in the near term of adding additional sales and field applications personnel in the Asia-Pacific region to further broaden our support and coverage of our existing end-customer base, in addition to developing new end-customer relationships and generating design wins. We also intend to continue to invest additional resources in research and development to support the development of our products and differentiated technologies. Any investments we make in our sales and marketing organization, or research and development will occur in advance of experiencing any benefits from such investments, and the return on these investments may be lower than we expect. In addition, as we invest in expanding our operations into new areas internationally, our business and results will become further subject to the risks and challenges of operations in those locations, including potentially higher operating expenses and the impact of legal and regulatory developments.

 

23


 

Components of Condensed Consolidated Statements of Income

Revenue

We derive substantially all of our revenue through the sale of our products to distributors who, in turn, sell to our end-customers, which consists of OEM, ODM, contract manufacturers and design houses. Revenue is recognized in accordance with Accounting Standards Codification Topic 606 after we (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) satisfy the performance obligation when control is transferred to the customer.

Cost of Revenue

Cost of revenue primarily consists of costs paid to our third-party manufacturers for wafer fabrication, assembly and testing of our products. To a lesser extent, cost of revenue also includes write-downs of inventory for excess and obsolete inventory, depreciation of test equipment, and expenses relating to manufacturing support activities, including personnel-related costs, logistics and quality assurance and shipping.

Research and Development Expenses

Research and development expenses consist primarily of compensation and associated costs of employees engaged in research and development, contractor costs, tape-out costs, development testing and evaluation costs, and depreciation expense. Before releasing new products, we incur charges for mask sets, prototype wafers and mask set revisions, which we refer to as tape-out costs. Tape-out costs may cause our research and development costs to increase in absolute dollars in the future as we increase our investment in new product development and headcount to support our development efforts.

Selling, General and Administrative Expenses

Selling expenses consist primarily of personnel-related costs for our sales, business development, marketing, and applications engineering activities, promotional and other marketing expenses, and travel expenses. We expect selling expenses to increase in absolute dollars for the foreseeable future as we continue to expand our sales teams and increase our marketing activities. General and administrative expenses consist primarily of personnel-related costs, consulting expenses, professional fees and facility costs. Professional fees principally consist of legal, audit, tax and accounting services. We expect general and administrative expenses to increase in absolute dollars for the foreseeable future as we hire additional personnel, make improvements to our infrastructure and incur significant additional costs for the compliance requirements of operating as a U.S. company that is publicly traded in Japan, including higher legal, insurance and accounting expenses. Personnel-related costs, including salaries, benefits, bonuses and stock-based compensation, are the most significant component of each of selling expenses and general and administrative expenses.

Provision for Income Taxes

The provision for income taxes consists of our estimated federal, state and foreign income taxes based on our pre-tax income. Our provision differs from the federal statutory rate primarily due to the research and development credit, foreign derived intangible income deduction and stock-based compensation deduction.

24


 

Results of Operations

The following table sets forth our condensed consolidated results of operations for the periods shown (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

$

18,486

 

 

$

17,511

 

 

$

51,576

 

 

$

46,951

 

Cost of revenue (1)

 

8,690

 

 

 

8,143

 

 

 

24,275

 

 

 

21,711

 

Gross profit

 

9,796

 

 

 

9,368

 

 

 

27,301

 

 

 

25,240

 

Operating expenses: (1)

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

2,583

 

 

 

1,803

 

 

 

6,502

 

 

 

5,346

 

Selling, general and administrative

 

2,404

 

 

 

2,255

 

 

 

7,528

 

 

 

7,148

 

Total operating expenses

 

4,987

 

 

 

4,058

 

 

 

14,030

 

 

 

12,494

 

Income from operations

 

4,809

 

 

 

5,310

 

 

 

13,271

 

 

 

12,746

 

Other income, net

 

911

 

 

 

550

 

 

 

2,343

 

 

 

1,504

 

Income before income taxes

 

5,720

 

 

 

5,860

 

 

 

15,614

 

 

 

14,250

 

Provision for income taxes

 

668

 

 

 

665

 

 

 

1,846

 

 

 

1,629

 

Net income

$

5,052

 

 

$

5,195

 

 

$

13,768

 

 

$

12,621

 

 

(1)
Includes stock-based compensation expense as follows (in thousands):

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

$

29

 

 

$

34

 

 

$

86

 

 

$

110

 

Research and development

 

157

 

 

 

166

 

 

 

457

 

 

 

400

 

Selling, general and administrative

 

214

 

 

 

206

 

 

 

651

 

 

 

626

 

Total

$

400

 

 

$

406

 

 

$

1,194

 

 

$

1,136

 

The following table sets forth the condensed consolidated statements of income for each of the periods as a percentage of revenue:

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

Cost of revenue

 

47

 

 

 

47

 

 

 

47

 

 

 

46

 

Gross profit

 

53

 

 

 

53

 

 

 

53

 

 

 

54

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

14

 

 

 

10

 

 

 

13

 

 

 

11

 

Selling, general and administrative

 

13

 

 

 

13

 

 

 

15

 

 

 

15

 

Total operating expenses

 

27

 

 

 

23

 

 

 

28

 

 

 

26

 

Income from operations

 

26

 

 

 

30

 

 

 

25

 

 

 

28

 

Other income, net

 

5

 

 

 

3

 

 

 

5

 

 

 

3

 

Income before income taxes

 

31

 

 

 

33

 

 

 

30

 

 

 

31

 

Provision for income taxes

 

4

 

 

 

4

 

 

 

4

 

 

 

3

 

Net income

 

27

%

 

 

29

%

 

 

26

%

 

 

28

%

 

25


 

Comparison of the Three and Nine Months Ended September 30, 2024 and September 30, 2023

Revenue

The components of revenue are as follows (dollars in thousands):

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Automotive

$

12,771

 

 

$

12,467

 

 

$

304

 

 

 

2

%

 

$

37,638

 

 

$

31,194

 

 

$

6,444

 

 

 

21

%

Security surveillance

 

5,715

 

 

 

5,044

 

 

 

671

 

 

 

13

%

 

$

13,938

 

 

 

15,757

 

 

 

(1,819

)

 

 

(12

)%

Revenue

$

18,486

 

 

$

17,511

 

 

$

975

 

 

 

6

%

 

$

51,576

 

 

$

46,951

 

 

$

4,625

 

 

 

10

%

Revenue increased by $1.0 million, or 6%, for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023. This was primarily attributable to a $0.7 million increase in security surveillance market revenue as a result of an increase in the volume of shipments, offset by a decrease in average selling prices attributable to product mix, and a $0.3 million increase in automotive revenue as a result of an increase in the volume of shipments, offset by a decrease in average selling prices attributable to product mix.

Revenue increased by $4.6 million, or 10%, for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023. This was primarily attributable to a $6.4 million increase in automotive market revenue as a result of an increase in volume of shipments, offset by a decrease in average selling prices attributable to product mix. Security surveillance market revenue decreased by $1.8 million due to a decrease in the volume of shipments and a decrease in average selling price attributable to product mix.

Our product pricing increases or decreases in our target markets in response to our increased or decreased manufacturing costs. Additionally, fluctuations in our overall average selling price are directly attributable to changes in product mix given the natural pricing variation of the products in our portfolio and customer base. When the product mix shifts towards the higher priced products in our portfolio, the average selling price will be higher than when the product mix shifts towards the lower price point products.

Revenue by geographic region

The table below sets forth revenue by geographic region as a percent of total revenue for the periods presented:

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

China

 

72

%

 

 

75

%

 

 

74

%

 

 

74

%

Taiwan

 

14

 

 

 

13

 

 

 

14

 

 

 

14

 

South Korea

 

9

 

 

 

8

 

 

 

8

 

 

 

9

 

Japan

 

2

 

 

 

2

 

 

 

1

 

 

 

2

 

Other

 

3

 

 

 

2

 

 

 

3

 

 

 

1

 

Total

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

Cost of revenue and gross margin (dollars in thousands)

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Cost of revenue

$

8,690

 

 

$

8,143

 

 

$

547

 

 

 

7

%

 

$

24,275

 

 

$

21,711

 

 

$

2,564

 

 

 

12

%

Gross margin

 

53

%

 

 

53

%

 

 

 

 

 

 

 

 

53

%

 

 

54

%

 

 

 

 

 

 

Cost of revenue increased by $0.5 million, or 7%, and gross margin remained flat at 53% for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023, respectively. Cost of revenue increased by $2.6 million, or 12%, and gross margin decreased to 53% from 54% for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, respectively. Gross margin for the three months and nine months ended September 30, 2024 was impacted by changes in product mix. We expect gross margins to fluctuate in future periods due to changes in customer and product mix, average unit selling prices, manufacturing costs, adjustments to inventory, if any, and end market product demand.

 

 

26


 

 

Research and development expense (dollars in thousands)

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Research and development

$

2,583

 

 

$

1,803

 

 

$

780

 

 

 

43

%

 

$

6,502

 

 

$

5,346

 

 

$

1,156

 

 

 

22

%

 

Research and development expenses increased by $0.8 million, or 43%, for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023, due to a $0.8 million increase in tape-out expenses associated with the development of new products.

 

Research and development expenses increased by $1.2 million, or 22 %, for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, primarily due to a $0.5 million increase in tape-out expenses associated with the development of new products, a $0.4 million increase in personnel-related expenses due to the increase in headcount as a result of expanding operations, and a $0.2 million increase in design software expenses.

Selling, general and administrative expense (dollars in thousands)

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Selling, general and administrative

$

2,404

 

 

$

2,255

 

 

$

149

 

 

 

7

%

 

$

7,528

 

 

$

7,148

 

 

$

380

 

 

 

5

%

 

Selling, general and administrative expenses increased by $0.1 million, or 7%, for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023, primarily due to a $0.1 million increase in professional service cost.

 

Selling, general and administrative expenses increased by $0.4 million, or 5%, for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, due to a $0.3 million increase in personnel-related expenses, and a $0.1 million increase in other administrative expenses.

Other income, net (dollars in thousands)

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Other income, net

$

911

 

 

$

550

 

 

$

361

 

 

 

66

%

 

$

2,343

 

 

$

1,504

 

 

$

839

 

 

 

56

%

 

Other income, net increased by $0.4 million, or 66%, for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023, due to an increase in interest income and gains related to foreign currency exchange transactions and foreign currency fluctuations.

 

Other income, net increased $0.8 million, or 56%, for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, due to a $0.7 million increase in interest income and gain related to foreign currency exchange transactions and foreign currency fluctuations, and a $0.1 million increase due to reimbursement of fixed asset purchased and depreciated previously.

Provision for income taxes (dollars in thousands)

 

Three Months Ended September 30,

 

 

Change

 

 

Nine Months Ended September 30,

 

 

Change

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

 

2024

 

 

2023

 

 

Amount

 

 

%

 

Provision for income taxes

$

668

 

 

$

665

 

 

$

3

 

 

 

0

%

 

$

1,846

 

 

$

1,629

 

 

$

217

 

 

 

13

%

 

27


 

The provision for income taxes remained flat with immaterial change for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023.

The provision for income taxes increased by $0.2 million, or 13%, for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, primarily due to an increase in profit before taxes.

Liquidity and Capital Resources

Our primary use of cash is to fund our operations as we continue to grow our business. Cash used to fund operating expenses is impacted by the timing of when we pay expenses, as reflected in the changes in our outstanding accounts payable and accrued expenses. Our cash, cash equivalents, and short-term investments as of September 30, 2024 were $68.5 million. We believe our existing cash, cash equivalents, short-term investments, and cash we expect to generate from operations in the future will be sufficient to meet our anticipated cash needs for at least the next 12 months.

In 2021, our board of directors adopted a dividend policy to link dividend payments to business performance on an ongoing basis. During the nine months ended September 30, 2024, cash used in financing activities consists primarily of $9.2 million in dividend payments to holders of our common stock (including common stock underlying JDS) under this recently adopted dividend policy.

Our future capital requirements will depend on many factors, including our growth rate, the timing and extent of our spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, the introduction of new and enhanced products and our costs to implement new manufacturing technologies or potentially acquire and integrate other companies or assets. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. Any debt financing obtained by us in the future could also involve restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. Additionally, if we raise additional funds through further issuances of equity, or issue convertible debt securities or other securities convertible into equity, our existing stockholders could suffer significant dilution in their percentage ownership, and any new equity securities we issue could have rights, preferences and privileges senior to those of holders of our common stock. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited.

A summary of operating, investing and financing activities are shown in the following table (in thousands):

 

Nine Months Ended

 

 

September 30,

 

 

2024

 

 

2023

 

Net cash provided by operating activities

$

10,753

 

 

$

17,529

 

Net cash provided by (used in) investing activities

 

31,073

 

 

 

(7,860

)

Net cash used in financing activities

 

(9,306

)

 

 

(9,217

)

Net increase in cash and cash equivalents

$

32,520

 

 

$

452

 

Operating Activities

Our primary source of cash from operating activities has been from cash collections from our customers. We expect cash flows from operating activities to be affected by fluctuations in sales. Our primary uses of cash from operating activities have been for personnel costs and investments in research and development and sales and marketing.

During the nine months ended September 30, 2024, net cash provided by operating activities was $10.8 million, due to net income of $13.8 million, net adjustments from non-cash charges of a $0.2 million deduction and net cash outflows from changes in operating assets and liabilities of $2.8 million.

Net adjustments from non-cash charges of a $0.2 million deduction primarily consisted of accretion of premium on available-for-sale investments of $1.0 million, an increase in deferred tax assets of $0.9 million, and gain on disposal of fixed asset of $0.1 million, partially offset by stock-based compensation of $1.2 million, amortization of operating lease right-of-use assets of $0.5 million, and depreciation and amortization of $0.2 million.

Net cash outflows from changes in operating assets and liabilities totaled $2.8 million, primarily consisting of a $4.2 million increase in inventory, net of valuation adjustment, as units manufactured during the period and on hand were in excess of product sales, a $0.3 million decrease in other liabilities, a $0.2 million decrease in lease liabilities, and a $0.2 million decrease in accounts

28


 

payable due to the timing of vendor payments. Outflows were partially offset by the inflow from a $1.4 million increase in accrued liabilities due to the timing of customer payments, and a $0.5 million increase in customer deposit.

During the nine months ended September 30, 2023, net cash provided by operating activities was $17.5 million, primarily due to net income of $12.6 million, non-cash charges of $0.8 million and net cash inflows from changes in operating assets and liabilities of $4.1 million. Non-cash charges consisted of stock-based compensation of $1.1 million, amortization of operating lease right-of-use assets of $0.4 million, an increase in the inventory valuation adjustment of $0.3 million, and depreciation and amortization of $0.3 million, partially offset by an increase in deferred tax assets of $0.9 million, and accretion of premium on available-for-sale investments of $0.5 million. Net cash inflows from changes in operating assets and liabilities totaled $4.1 million, consisting of a $1.9 million decrease in inventory, net of valuation adjustment, as units manufactured during the period and on hand were less than product sales, a $1.5 million increase in customer deposit and a $1.3 million increase in accrued liabilities due to the timing of customer payments. Inflows were partially offset by outflows from a $0.4 million decrease in lease and other liabilities, and a $0.2 million increase in prepaid expense and other current asset due to timing of payments.

Investing Activities

During the nine months ended September 30, 2024, cash provided by investing activities was $31.1 million, primarily attributable to proceeds from maturity of debt securities, net of investments in debt securities.

During the nine months ended September 30, 2023, cash used in investing activities was $7.9 million, primarily consisting of a $5.9 million cash outflow due to purchase of debt securities, net of proceeds from maturity of debt security, a $1.7 million in acquisition of business and intangible assets, and a $0.2 million in purchase of property and equipment.

Financing Activities

During the nine months ended September 30, 2024, cash used in financing activities was approximately $9.3 million, primarily due to payment of dividends totaling $9.2 million in February and July, 2024.

 

During the nine months ended September 30, 2023, cash used in financing activities was approximately $9.2 million, primarily due to payment of dividends totaling $9.1 million in February and July, 2023.

29


 

Contractual Obligations

Our outstanding contractual obligations as of September 30, 2024 are summarized in the following table (in thousands):

 

 

 

 

 

Payments Due by Period

 

 

Total

 

 

Less than 1 year

 

 

1 to 3 years

 

Purchase commitments

 

$

1,534

 

 

 

1,096

 

 

 

438

 

Operating leases

 

 

1,270

 

 

 

741

 

 

 

529

 

Obligations under contracts that we can cancel without a significant penalty are not included in the table above. We believe our cash provided by operations is sufficient to satisfy our contractual obligations for all periods presented.

Off-Balance Sheet Arrangements

During the periods presented, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Critical Accounting Policies, Significant Estimates and Judgments

Our financial statements are prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates, assumptions, and judgments on an ongoing basis. Our estimates, assumptions and judgments are based on historical experience and various other factors that we believe to be reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our financial statements, which, in turn, could change the results from those reported. Please see Note 1 of Part I, Item 1 of this Quarterly Report on Form 10-Q for a summary of significant accounting policies and Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 for a summary of our critical accounting estimates.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risk from fluctuations in foreign currency exchange rates and interest rates, which may adversely affect our results of operations and financial condition. We seek to minimize these risks through regular operating activities. We do not purchase, hold or sell derivative financial instruments for trading or speculative purposes.

Foreign exchange rates

We transact business globally and are subject to risks associated with fluctuating foreign exchange rates. Substantially all of our revenue was derived from sales outside of the U.S. in the nine months ended September 30, 2024 and 2023. This revenue is generated in U.S. dollars with sales through distributors worldwide. Our operating expenses are denominated in the currencies of the countries in which our subsidiaries are located and may be subject to fluctuations due to changes in foreign currency exchange rates. To date, we have not entered into any hedging contracts, but may elect to do so in the future. A hypothetical increase or decrease of 10% in foreign exchange rates for the nine months ended September 30, 2024 and 2023 would not have resulted in a significant increase or decrease in revenue or net income during that period.

The U.S. dollar is the functional currency for all of our foreign operations. Monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency of the subsidiary at the balance sheet date. The gains and losses from remeasurement of foreign currency denominated balances into the functional currency of the subsidiary are included in other income (expense), net on our condensed consolidated statements of income and comprehensive income.

Interest rates

Our exposure to market risk for changes in interest rates relates primarily to our cash, cash equivalents and investments. Our cash, cash equivalents and investments consist primarily of cash, U.S. treasury bills, government agency bonds, money market funds, corporate notes and bonds, and commercial paper. The primary objectives of our investment activities are the preservation of capital, the maintenance of liquidity, and capturing a market rate of return. We seek to minimize risk by investing cash in excess of our operating needs in high-quality instruments issued by highly creditworthy financial institutions. We do not purchase investments for trading or speculative purposes. Due to the nature of these instruments, we believe that we do not have any material exposure to

30


 

changes in the fair value of our investment portfolio as a result of changes in interest rates. Decreases in interest rates, however, would reduce future interest income.

A hypothetical increase or decrease of 10% in interest rates in the nine months ended September 30, 2024 and 2023 would not have resulted in a significant increase or decrease in cash, cash equivalents or the fair value of our investment during those periods.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on management’s evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective at a reasonable assurance level.

In designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

31


 

PART II—OTHER INFORMATION

Although we are not currently a party to any legal proceedings, and no legal proceeding is currently threatened against us, we may be subject to legal proceedings, claims and litigation, including intellectual property litigation, arising in the ordinary course of business. Such matters are subject to many uncertainties and outcomes and are not predictable with assurance. We accrue amounts that we believe are adequate to address any liabilities related to legal proceedings and other loss contingencies that we believe may result in a probable loss that is reasonably estimable.

Item 1A. Risk Factors.

There have been no material changes to the previously disclosed risk factors discussed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023. You should consider carefully these factors, together with all of the other information in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, before making an investment decision.

Item 5. Other Information.

(c) Trading Plans.

During the three months ended September 30, 2024, no director or officer adopted or terminated any contract, instruction or written plan for the purchase or sale of securities of the Company pursuant to Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).

 

 

32


 

Item 6. Exhibits.

 

Exhibit

Number

Description

 

 

 

31.1

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a).

 

 

 

31.2

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a).

 

 

 

32.1*

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2*

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

# Indicates management contract or compensatory plan or arrangement.

 

* In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933 except to the extent that the registrant specifically incorporates it by reference.

33


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Techpoint, Inc.

Date: November 8, 2024

By:

/s/ Fumihiro Kozato

Fumihiro Kozato

President and Chief Executive Officer

(Principal Executive Officer)

 

Date: November 8, 2024

By:

/s/ Michelle P. Ho

Michelle P. Ho

Interim Chief Financial Officer

(Principal Financial Officer)

 

34